These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 13348337)

  • 1. [Oral treatment of diabetes mellitus with a sulfonamide derivative; N1-sulfanilyn-N2-n-butyl carbamide].
    ANGELI G; TEDESCHI G
    Minerva Med; 1956 Jun; 47(50):1968-75. PubMed ID: 13348337
    [No Abstract]   [Full Text] [Related]  

  • 2. [Uses of BZ 55: a sulfonamide derivative for oral administration].
    ROOT HF; CAMERINI DAVALOS R
    Dia Med; 1956 Jun; 28(43):1205-16. PubMed ID: 13344309
    [No Abstract]   [Full Text] [Related]  

  • 3. [Oral treatment of diabetes mellitus with N-4-methyl-benzolsulfonyl-N'-butyl-urea (D-860); clinical and experimental research].
    Dtsch Med Wochenschr; 1956 Jun; 81(22):887-960; concl. PubMed ID: 13344014
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hypoglycemic effect of new sulfonamide N1-sulfanilyl-N2-n-butyl-carbamide (Bz 55) in surgical patients].
    CORTINOVIS R
    Riforma Med; 1956 Jul; 70(27):764-7. PubMed ID: 13351284
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of N1-sulphanylil-N2-n butylurea in diabetes mellitus].
    DI LORENZO S; MIOLA A
    Riforma Med; 1956 Jun; 70(22):619-23. PubMed ID: 13351267
    [No Abstract]   [Full Text] [Related]  

  • 6. [Preliminary note on the oral treatment of diabetes by N-sulfonyl-p-methylbenzene-N'-n-butyl urea or D 860, a product free of antibacterial action].
    MOREAU R; DEUIL R; SARRAZIN A; DE TRAVERSE PM; MARTINET M
    Presse Med (1893); 1956 Jul; 64(54):1261-4. PubMed ID: 13350129
    [No Abstract]   [Full Text] [Related]  

  • 7. [Oral therapy of diabetes mellitus by N-tolyl-sulfonyl-N'-butyl urea (D 860); clinical and experimental studies].
    BANDER A; CREUTZFELDT W; DORFMULLER T; EHRHART H; MARX R; MASKE H; MEIER W; MOHNIKE G; PFEIFFER EF; SCHLAGINTWEIT S; SCHOFFLING K; SCHOLZ J; SEIDLER I; STEIGERWALD H; STICH W; STOTTER G; ULRICH H
    Dtsch Med Wochenschr; 1956 May; 81(21):823-46; contd. PubMed ID: 13330473
    [No Abstract]   [Full Text] [Related]  

  • 8. [A new anti-diabetic principle for oral administration].
    FRANKEL PE
    Rev Bras Med; 1956 Apr; 13(4):267-8. PubMed ID: 13350696
    [No Abstract]   [Full Text] [Related]  

  • 9. [Preliminary experiences with the sulfonamide nadisan in therapy of diabetes].
    BROGLIE M; VOSS G; BERG EG; RUHLING O
    Medizinische; 1956 Apr; (17):656-9. PubMed ID: 13321484
    [No Abstract]   [Full Text] [Related]  

  • 10. [N-tolyl-sulfonyl-N'-butyl urea in the ambulatory therapy of diabetes].
    FRANCHI G
    Gazz Med Ital; 1957 Jan; 116(1):1-12. PubMed ID: 13427964
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antidiabetic effect of a new sulfonamide].
    TOLOMELLI E; PELLEGRINI R; POPPI A
    Riforma Med; 1956 Feb; 70(7):180-3. PubMed ID: 13311263
    [No Abstract]   [Full Text] [Related]  

  • 12. [Results and clinical aspects of new oral treatment of diabetes mellitus with N-butylsulfanilylurea BZ-55].
    INTROZZI P; MARIGO S
    Minerva Med; 1956 Jun; 47(50):1959-66. PubMed ID: 13348335
    [No Abstract]   [Full Text] [Related]  

  • 13. [Ambulatory treatment of diabetics with a hypoglycemic sulfonamide].
    RAMEL C; HOFSTETTER JR
    Praxis; 1956 Apr; 45(16):365-9. PubMed ID: 13335688
    [No Abstract]   [Full Text] [Related]  

  • 14. Oral treatment of diabetes.
    FISHER AM
    Can J Public Health; 1956 Jul; 47(7):296-7. PubMed ID: 13343054
    [No Abstract]   [Full Text] [Related]  

  • 15. [Oral therapy of diabetes mellitus with invenol].
    BLOCH J; LENHARDT A
    Wien Med Wochenschr; 1956 Jul; 106(27):594-8. PubMed ID: 13353170
    [No Abstract]   [Full Text] [Related]  

  • 16. [Peroral treatment of diabetes. II. Oral treatment of diabetes mellitus with D 860].
    KUHLMANN F
    Med Klin; 1956 Nov; 51(45):1919-21. PubMed ID: 13386836
    [No Abstract]   [Full Text] [Related]  

  • 17. [New possibilities in the therapy of diabetes; critical report on an oral antidiabetic drug].
    STEIGERWALDT F
    Med Monatsschr; 1955 Dec; 9(12):793-5. PubMed ID: 13296832
    [No Abstract]   [Full Text] [Related]  

  • 18. The relation of various variables to the hypoglycemic action of 1-butyl-3-p-tolylsulfonylurea in patients with diabetes mellitus.
    DIENGOTT D; DOLGER H; MIRSKY IA
    Metabolism; 1956 Nov; 5(6 Part 2):875-93. PubMed ID: 13378057
    [No Abstract]   [Full Text] [Related]  

  • 19. [Results of the treatment of diabetes with new sulfonamide-urea preparations].
    PUKHLEV A; TIKHOLOV K
    Suvr Med (Sofiia); 1957; 8(1):21-33. PubMed ID: 13455446
    [No Abstract]   [Full Text] [Related]  

  • 20. [Oral therapy of diabetes with sulfanyl urea derivatives].
    OTTO H
    Riforma Med; 1957 May; 71(18):489-93. PubMed ID: 13442483
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.